Company intelligence / Profile preview

Renovo

Overview

Lead drug Juvista failed Phase III clinical trials for scar reduction; all staff laid off in May 2011; no marketed products.

Shire Pharmaceuticals – development/commercialization of Juvista outside EU member states.

Beyond the preview

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Follow clinical development from trial design and recruitment through results.

Explore licensing agreements, acquisitions, and the assets behind each deal.

Trace financing activity and the investors behind a company’s development.

Compare peer pipelines by target, modality, and therapeutic area.

Explore technology platforms and the patent landscape around relevant assets.

Connect company news and source material to the questions you’re investigating.

See how Gosset can support your research on Renovo.